Guideline-directed medical therapy (GDMT)

The four-pillar pharmacotherapy regimen for HFrEF: ARNI or ACE inhibitor/ARB, evidence-based beta-blocker, mineralocorticoid receptor antagonist, and SGLT2 inhibitor. Each pillar reduces mortality independently.

Study heart failure lessons·Practice questions